Contract facts
FederalNo full NAICS 325413 intel page yet. Browse NAICS intelligence
Contractor Shall Provide Cobas 6000 Chemical Analyzer, Reagents and Test Kits as Defined in the Performance Work Statem… is a federal award for Fa3020 82 Cons Lgc held by Roche Diagnostics Corp. Estimated value $115K ($-22,281.1 obligated). Current period of performance ends Sep 30, 2022. Place of performance: SHEPPARD AFB TX.
Contractor shall provide cobas 6000 chemical analyzer, reagents and test kits as defined in the performance work statement and in accordance with the price lists and contract requirements. Latest action is a modification.
Recompete timing
PublicCurrent PoP ended Sep 30, 2022 (1482 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Want the durability read on FA302022F0019? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordRoche Diagnostics Corp — $245.9M obligated across 1,391 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract FA302022F0019?
FA302022F0019 (Contractor shall provide cobas 6000 chemical) is a Fa3020 82 Cons Lgc award with a potential value of $115K, currently held by Roche Diagnostics Corp. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is FA3020-22-F-0019?
FA3020-22-F-0019 is the dashed form of PIID FA302022F0019 (Contractor shall provide cobas 6000 chemical), held by Roche Diagnostics Corp. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded FA302022F0019?
Fa3020 82 Cons Lgc awarded FA302022F0019 to Roche Diagnostics Corp (potential $115K).
Who is the incumbent on FA302022F0019?
Roche Diagnostics Corp is the incumbent with $245.9M across 1391 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2022.
When does Roche Diagnostics Corp’s FA302022F0019 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 30, 2022. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on FA302022F0019? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.